The UK Department of Health and Social Care has introduced an updated Group Direction (VGD) template designed to simplify influenza vaccine administration across England’s healthcare system for the 2024–25 season. The framework authorises pharmacists, nurses, health visitors, and other qualified professionals to administer both inactivated (IIV) and live attenuated (LAIV) influenza vaccines under a single protocol, eliminating the need for individual patient prescriptions.
This standardised approach addresses a persistent administrative bottleneck in seasonal immunisation campaigns. By removing prescribing barriers, the updated template enables faster vaccine deployment across community pharmacies, general practices, and primary care settings. The framework maintains clinical rigour through integrated contraindication criteria, patient eligibility verification, and post-vaccination safety monitoring protocols.
Healthcare leaders view the unified VGD as a strategic advancement in vaccine accessibility, particularly for vulnerable populations requiring timely protection during peak influenza season. Read the full article on GMJ Newsroom.
Was this article helpful?
